Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
67
RCAT Quote, Financials, Valuation and Earnings
Last price:
$12.22
Seasonality move
:
23.6%
Day range:
$10.11 - $11.55
52-week range:
$1.64 - $15.27
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
72.60x
P/B ratio:
39.01x
Volume:
14.9M
Avg. volume:
11.9M
1-year change:
500%
Market cap:
$1.1B
Revenue:
$4.9M
EPS (TTM):
-$0.71
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $4.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -72.81% | |
| Cost of Revenues | -- | -- | -- | -- | $6.2M | |
| Gross Profit | -- | -- | -- | -- | -$1.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -27.96% | |
| R&D Expenses | -- | -- | -- | -- | $6.6M | |
| Selling, General & Admin | -- | -- | -- | -- | $17.8M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -$17.9M | |
| Operating Expenses | -- | -- | -- | -- | $24.4M | |
| Operating Income | -- | -- | -- | -- | -$25.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -$43.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -$43.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -$43.6M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$0.57 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$0.57 | |
| Weighted Average Basic Share | -- | -- | -- | -- | $77M | |
| Weighted Average Diluted Share | -- | -- | -- | -- | $77M | |
| EBITDA | -- | -- | -- | -- | -$24.3M | |
| EBIT | -- | -- | -- | -- | -$25.7M | |
| Revenue (Reported) | -- | -- | -- | -- | $4.9M | |
| Operating Income (Reported) | -- | -- | -- | -- | -$25.7M | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -$25.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $1.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -72.13% | |
| Cost of Revenues | -- | -- | -- | -- | $2.5M | |
| Gross Profit | -- | -- | -- | -- | -$850.4K | |
| Gross Profit Margin | -- | -- | -- | -- | -52.18% | |
| R&D Expenses | -- | -- | -- | -- | $3.4M | |
| Selling, General & Admin | -- | -- | -- | -- | $8.2M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -$10.7M | |
| Operating Expenses | -- | -- | -- | -- | $11.6M | |
| Operating Income | -- | -- | -- | -- | -$12.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -$23.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -$23.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -$23.1M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$0.27 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$0.27 | |
| Weighted Average Basic Share | -- | -- | -- | -- | $85.5M | |
| Weighted Average Diluted Share | -- | -- | -- | -- | $85.5M | |
| EBITDA | -- | -- | -- | -- | -$11.9M | |
| EBIT | -- | -- | -- | -- | -$12.5M | |
| Revenue (Reported) | -- | -- | -- | -- | $1.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -$12.5M | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -$12.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $12.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | $12.4M | |
| Gross Profit | -- | -- | -- | -- | -$153.6K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | $8.3M | |
| Selling, General & Admin | -- | -- | -- | -- | $27.3M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -$21.5M | |
| Operating Expenses | -- | -- | -- | -- | $33.9M | |
| Operating Income | -- | -- | -- | -- | -$34.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -$55.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -$384.6K | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -$58.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -$55.9M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$0.71 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$0.71 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -$31.5M | |
| EBIT | -- | -- | -- | -- | -$33.3M | |
| Revenue (Reported) | -- | -- | -- | -- | $12.3M | |
| Operating Income (Reported) | -- | -- | -- | -- | -$34.1M | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -$33.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.1M | $1.9M | $1.7M | $5.8M | $1.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.6M | $1.5M | $1.8M | $4.7M | $2.5M | |
| Gross Profit | $569.7K | $339.8K | -$96.9K | $1.1M | -$850.4K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $168K | $811.3K | $1.2M | $2.1M | $3.4M | |
| Selling, General & Admin | $1.4M | $2.4M | $3.2M | $2.9M | $8.2M | |
| Other Inc / (Exp) | -$7.8M | $645.5K | -$123.2K | $273.5K | -$10.7M | |
| Operating Expenses | $1.7M | $3.5M | $5.1M | $5.5M | $11.6M | |
| Operating Income | -$1.1M | -$3.2M | -$5.2M | -$4.4M | -$12.5M | |
| Net Interest Expenses | -- | $46.6K | $28.7K | $15.5K | -- | |
| EBT. Incl. Unusual Items | -$9M | -$2.6M | -$5.3M | -$4.2M | -$23.1M | |
| Earnings of Discontinued Ops. | -- | -- | -$330.1K | -$1.3M | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$9M | -$2.6M | -$5.3M | -$2.3M | -$23.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$9M | -$2.6M | -$5.7M | -$5.5M | -$23.1M | |
| Basic EPS (Cont. Ops) | -$0.34 | -$0.05 | -$0.10 | -$0.10 | -$0.27 | |
| Diluted EPS (Cont. Ops) | -$0.34 | -$0.05 | -$0.10 | -$0.10 | -$0.27 | |
| Weighted Average Basic Share | $26.2M | $53.6M | $54.3M | $55.7M | $85.5M | |
| Weighted Average Diluted Share | $26.2M | $53.6M | $54.3M | $55.7M | $85.5M | |
| EBITDA | -$9M | -$2.5M | -$5M | -$3.8M | -$11.9M | |
| EBIT | -$9M | -$2.5M | -$5.3M | -$4.2M | -$12.5M | |
| Revenue (Reported) | $2.1M | $1.9M | $1.7M | $5.8M | $1.6M | |
| Operating Income (Reported) | -$1.1M | -$3.2M | -$5.2M | -$4.4M | -$12.5M | |
| Operating Income (Adjusted) | -$9M | -$2.5M | -$5.3M | -$4.2M | -$12.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $9.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | $489.3K | |
| Inventory | -- | -- | -- | -- | $13M | |
| Prepaid Expenses | -- | -- | -- | -- | $3.2M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | -- | $25.8M | |
| Property Plant And Equipment | -- | -- | -- | -- | $3.4M | |
| Long-Term Investments | -- | -- | -- | -- | $250K | |
| Goodwill | -- | -- | -- | -- | $17.7M | |
| Other Intangibles | -- | -- | -- | -- | $8.5M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | $55.6M | |
| Accounts Payable | -- | -- | -- | -- | $2M | |
| Accrued Expenses | -- | -- | -- | -- | $1.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $350K | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $311.5K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $4.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | $5.5M | |
| Common Stock | -- | -- | -- | -- | $85.3K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | $50.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | $50.1M | |
| Total Liabilities and Equity | -- | -- | -- | -- | $55.6M | |
| Cash and Short Terms | -- | -- | -- | -- | $9.2M | |
| Total Debt | -- | -- | -- | -- | $350K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $7.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | $1.6M | |
| Inventory | -- | -- | -- | -- | $13.9M | |
| Prepaid Expenses | -- | -- | -- | -- | $3.3M | |
| Other Current Assets | -- | -- | -- | -- | $3M | |
| Total Current Assets | -- | -- | -- | -- | $29.4M | |
| Property Plant And Equipment | -- | -- | -- | -- | $4.2M | |
| Long-Term Investments | -- | -- | -- | -- | $250K | |
| Goodwill | -- | -- | -- | -- | $17.7M | |
| Other Intangibles | -- | -- | -- | -- | $8M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | $59.7M | |
| Accounts Payable | -- | -- | -- | -- | $1.5M | |
| Accrued Expenses | -- | -- | -- | -- | $1.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $25.1M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $491K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $28.9M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | $30.7M | |
| Common Stock | -- | -- | -- | -- | $85.7K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | $28.9M | |
| Total Liabilities and Equity | -- | -- | -- | -- | $59.7M | |
| Cash and Short Terms | -- | -- | -- | -- | $7.7M | |
| Total Debt | -- | -- | -- | -- | $25.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -$43.6M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $1.4M | |
| Stock-Based Compensation | -- | -- | -- | -- | $4.1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | $3.9M | |
| Change in Inventories | -- | -- | -- | -- | -$4.6M | |
| Cash From Operations | -- | -- | -- | -- | -$20.5M | |
| Capital Expenditures | -- | -- | -- | -- | $163.6K | |
| Cash Acquisitions | -- | -- | -- | -- | $4.4M | |
| Cash From Investing | -- | -- | -- | -- | $4.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $13.5M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$394.6K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | $19.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | $6.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | $3.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | $9.2M | |
| Levered Free Cash Flow | -- | -- | -- | -- | -$20.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -$23.1M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $587.6K | |
| Stock-Based Compensation | -- | -- | -- | -- | $1.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -$1.1M | |
| Change in Inventories | -- | -- | -- | -- | -$3.5M | |
| Cash From Operations | -- | -- | -- | -- | -$15.9M | |
| Capital Expenditures | -- | -- | -- | -- | $273.1K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -$273.1K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $14.4M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | $14.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | $9.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -$1.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | $7.7M | |
| Levered Free Cash Flow | -- | -- | -- | -- | -$16.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -$58.1M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $1.8M | |
| Stock-Based Compensation | -- | -- | -- | -- | $5.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | $3.1M | |
| Change in Inventories | -- | -- | -- | -- | -$6.3M | |
| Cash From Operations | -- | -- | -- | -- | -$30.8M | |
| Capital Expenditures | -- | -- | -- | -- | $471.5K | |
| Cash Acquisitions | -- | -- | -- | -- | $4.4M | |
| Cash From Investing | -- | -- | -- | -- | $4.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$543K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | $21.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -$4.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -$31.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9M | -$2.6M | -$5.3M | -$2.3M | -$23.1M | |
| Depreciation & Amoritzation | $5.6K | $28.8K | $295.3K | $350.9K | $587.6K | |
| Stock-Based Compensation | $854.2K | $782.1K | $1.9M | $585.8K | $1.6M | |
| Change in Accounts Receivable | -$63.3K | -$497.8K | -$1.2M | -$2.1M | -$1.1M | |
| Change in Inventories | -$314.2K | -$354.2K | -$2.1M | $162.4K | -$3.5M | |
| Cash From Operations | -$348.6K | -$3.5M | -$7.3M | -$4.1M | -$15.9M | |
| Capital Expenditures | -- | $62.4K | $454.9K | $44.7K | $273.1K | |
| Cash Acquisitions | -$48.4K | -- | -- | -- | -- | |
| Cash From Investing | -$48.4K | -$386.1K | $10.3M | $2.6M | -$273.1K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $505.4K | -- | -- | -- | $14.4M | |
| Long-Term Debt Repaid | -$182.6K | -$373.8K | -$131.2K | -$144.7K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $65.8K | -$216.8K | -$33.1K | -$7.3K | -- | |
| Cash From Financing | $388.5K | -$590.5K | -$164.2K | $8.2M | $14.7M | |
| Beginning Cash (CF) | $480.1K | $11.6M | $1.6M | $1.4M | $9.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$8.4K | -$4.4M | $2.3M | $6.4M | -$1.4M | |
| Ending Cash (CF) | $471.7K | $7.1M | $3.9M | $7.8M | $7.7M | |
| Levered Free Cash Flow | -$348.6K | -$3.5M | -$7.7M | -$4.2M | -$16.2M | |
Get RCAT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RCAT
Sector
P/E ratio
--
23.84x
PEG ratio
-0.55x
0.00x
P/B ratio
39.01x
2.31x
Price / LTM sales
72.60x
1.64x
Growth Metrics
RCAT
Sector
Revenue growth
-72.13%
3.84%
Earnings growth
--
10.8%
Revenue (5-year growth)
64.4%
6.27%
Earnings forecast
-$0.12
$0.12
Profitability
RCAT
Sector
Profitability FY 2024
-$1.4M
$77.3M
Return on invested capital
-126.27%
0.05%
Return on assets
-110.76%
-0.48%
Return on equity
-154.1%
0.73%
Earnings Date
Last Earnings Date
May
14
Next Earnings Date
Aug
15
Estimated Next Earnings Date
Aug
13
Balance Sheet
RCAT
Sector
Total cash
$7.7M
$48.7M
Short term investments
--
$19.4M
Total assets
$55.6M
$223.8M
Long term debt
$25.5M
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
